
Intrasense S.A (ALINS) | Financial Analysis & Statements
Intrasense S.A. | Small-cap | Healthcare
Intrasense S.A. | Small-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
7.7M
Total Liabilities
6.0M
Shareholders Equity
1.7M
Debt to Equity
3.65
Cash Flow Metrics
Revenue & Profitability Trend
Intrasense S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.2M | 3.3M | 3.8M | 4.2M | 3.4M |
Cost of Goods Sold | 686.0K | 361.0K | 245.0K | 648.0K | 507.0K |
Gross Profit | 1.6M | 2.9M | 3.5M | 3.5M | 2.9M |
Gross Margin % | 69.5% | 89.1% | 93.5% | 84.5% | 85.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 125.0K | 84.0K | 126.0K | 1.1M | 711.0K |
Other Operating Expenses | 1.7M | 1.6M | 2.0M | 161.0K | 248.0K |
Total Operating Expenses | 1.8M | 1.7M | 2.1M | 1.2M | 959.0K |
Operating Income | -5.6M | -3.5M | -3.4M | -1.2M | -519.0K |
Operating Margin % | -249.5% | -106.1% | -89.0% | -27.5% | -15.1% |
Non-Operating Items | |||||
Interest Income | 50.0K | 50.0K | 3.0K | - | 7.0K |
Interest Expense | 45.0K | 46.0K | 40.0K | 17.0K | 49.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -5.7M | -3.6M | -3.4M | -1.2M | -705.0K |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -5.7M | -3.6M | -3.4M | -1.2M | -705.0K |
Net Margin % | -251.7% | -108.3% | -90.2% | -28.7% | -20.5% |
Key Metrics | |||||
EBITDA | -4.3M | -2.7M | -2.1M | -571.0K | 70.0K |
EPS (Basic) | - | -€0.07 | -€0.11 | -€0.04 | -€0.04 |
EPS (Diluted) | - | -€0.07 | -€0.11 | -€0.04 | -€0.04 |
Basic Shares Outstanding | - | 51334243 | 31327414 | 27913346 | 22924207 |
Diluted Shares Outstanding | - | 51334243 | 31327414 | 27913346 | 22924207 |
Income Statement Trend
Intrasense S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 930.0K | 4.6M | 1.4M | 4.8M | 2.6M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 323.0K | 609.0K | 1.0M | 1.5M | 1.0M |
Inventory | - | - | - | - | 125.0K |
Other Current Assets | 1.0K | - | 1.0K | - | -96.0K |
Total Current Assets | 2.4M | 6.4M | 3.5M | 6.7M | 4.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 4.6M | 3.3M | 2.2M | 1.2M | 1.2M |
Intangible Assets | 4.6M | 3.3M | 2.2M | 1.2M | 1.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | -1.0K | 1.0K | - | - | -1.0K |
Total Non-Current Assets | 5.3M | 4.1M | 3.0M | 2.1M | 2.1M |
Total Assets | 7.7M | 10.5M | 6.5M | 8.8M | 6.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 526.0K | 410.0K | 735.0K | 440.0K | 276.0K |
Short-term Debt | 504.0K | 327.0K | 634.0K | 457.0K | 253.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.4M | 3.0K | 162.0K | 14.0K | 8.0K |
Total Current Liabilities | 5.0M | 1.8M | 2.8M | 2.1M | 2.0M |
Non-Current Liabilities | |||||
Long-term Debt | 901.0K | 1.2M | 1.4M | 1.5M | 2.0M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | 27.0K | -1.0K | -1.0K | 1.0K |
Total Non-Current Liabilities | 1.1M | 1.3M | 1.7M | 1.7M | 2.2M |
Total Liabilities | 6.0M | 3.2M | 4.5M | 3.8M | 4.2M |
Equity | |||||
Common Stock | 2.6M | 2.6M | 1.6M | 1.6M | 1.2M |
Retained Earnings | -5.7M | -3.6M | -3.4M | -1.2M | -704.0K |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.7M | 7.3M | 2.0M | 5.0M | 2.2M |
Key Metrics | |||||
Total Debt | 1.4M | 1.5M | 2.1M | 1.9M | 2.3M |
Working Capital | -2.6M | 4.5M | 699.0K | 4.6M | 2.3M |
Balance Sheet Composition
Intrasense S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -5.7M | -3.6M | -3.4M | -1.2M | -704.0K |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 491.0K | -59.0K | -791.0K | -524.0K | -404.0K |
Operating Cash Flow | -5.2M | -3.4M | -4.2M | -1.7M | -1.1M |
Investing Activities | |||||
Capital Expenditures | -2.2M | -1.9M | -1.5M | -554.0K | -596.0K |
Acquisitions | - | - | - | - | - |
Investment Purchases | -2.0K | -1.0K | -1.0K | -1.0K | 0 |
Investment Sales | - | - | - | - | 45.0K |
Investing Cash Flow | -2.2M | -1.9M | -1.5M | -555.0K | -551.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 153.0K | 64.0K | 592.0K | 30.0K | 741.0K |
Debt Repayment | -316.0K | -649.0K | -456.0K | -355.0K | -270.0K |
Financing Cash Flow | 2.3M | 8.1M | 137.0K | 3.7M | 2.8M |
Free Cash Flow | -5.9M | -5.0M | -3.4M | -1.5M | -1.0M |
Net Change in Cash | -5.0M | 2.7M | -5.6M | 1.4M | 1.1M |
Cash Flow Trend
Intrasense S.A Key Financial Ratios
Valuation Ratios
Forward P/E
-5.68
Price to Book
9.16
Price to Sales
6.78
PEG Ratio
-5.68
Profitability Ratios
Profit Margin
-251.78%
Operating Margin
-339.60%
Return on Equity
-126.47%
Return on Assets
-38.68%
Financial Health
Current Ratio
0.48
Debt to Equity
84.95
Beta
-0.02
Per Share Data
EPS (TTM)
-€0.11
Book Value per Share
€0.03
Revenue per Share
€0.04
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
alins | 15.2M | - | 9.16 | -126.47% | -251.78% | 84.95 |
Equasens | 772.6M | 16.53 | 3.34 | 16.13% | 16.72% | 25.65 |
Cegedim S.A | 143.2M | 92.86 | 0.54 | -4.95% | -2.25% | 115.34 |
Abl Diagnostics | 86.8M | 535.00 | 11.51 | 4.00% | 4.86% | 34.10 |
Smaio S.A | 36.9M | 16.30 | 4.98 | -29.15% | -42.73% | 33.75 |
Ama Corp Plc | 14.4M | - | 5.72 | -176.91% | -294.90% | 159.28 |
Financial data is updated regularly. All figures are in the company's reporting currency.